INC Research, SAS Collaborate to Improve Clinical Trials Outcomes
INC Research and SAS are working together to improve clinical development risk management and achieve targeted product profiles through analytics. Collaborating with SAS, INC Research aims to offer biopharmaceutical customers an integrated suite of tools to increase decision-making speed, efficiency, and flexibility. The ultimate goal is to improve a customer’s ability to manage risk, control investment, and maximize ROI in clinical development.
“In an environment of growing trial complexity and shrinking R&D budgets, our biopharmaceutical customers demand innovative solutions and enhanced efficiencies in drug development,” said James Ogle, INC Research Chief Executive Officer. “By joining forces with SAS and its advanced analytics platform, INC Research aims to help customers better predict commercially successful outcomes earlier in the process to maximize development efforts.”
SAS’ advanced analytics platform will boost INC Research’s ability to optimize clinical trial designs and proactively manage operations. By gaining access to SAS software through a hosted delivery model, INC Research hopes customers will achieve more rapid and informed decisions, faster time to market, and improved cash flow.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
